Luciferase News and Research

RSS
Scientists successfully restore circadian function in the liver of arrhythmic mice

Scientists successfully restore circadian function in the liver of arrhythmic mice

New SARS-CoV-2 variants resistant to convalescent sera and and monoclonal antibodies

New SARS-CoV-2 variants resistant to convalescent sera and and monoclonal antibodies

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

ACE2 receptor is responsible for the wide host range of SARS-CoV-2

ACE2 receptor is responsible for the wide host range of SARS-CoV-2

A common compound in mouthwashes found to inhibit SARS-CoV-2 in vitro

A common compound in mouthwashes found to inhibit SARS-CoV-2 in vitro

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Reliable Antibodies Testing for SARS-CoV-2

Reliable Antibodies Testing for SARS-CoV-2

Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro

Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro

Researchers discover unique anti-cancer function for previously well-characterized protein

Researchers discover unique anti-cancer function for previously well-characterized protein

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Initial lockdown in France substantially curbed COVID-19, but many remain susceptible to the virus

Initial lockdown in France substantially curbed COVID-19, but many remain susceptible to the virus

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Proteolytic activation of the SARS-CoV-2 spike S1/S2 site

Proteolytic activation of the SARS-CoV-2 spike S1/S2 site

SARS-CoV-2 infects human embryonic epithelial and lung cells

SARS-CoV-2 infects human embryonic epithelial and lung cells

Bacteria-free method for making SARS-CoV-2 infectious clones

Bacteria-free method for making SARS-CoV-2 infectious clones

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo